EDEM2 Antikörper
Kurzübersicht für EDEM2 Antikörper (ABIN7113869)
Target
Alle EDEM2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- EDEM2 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- ER degradation enhancer, mannosidase alpha-like 2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))
-
Andere Bezeichnung
- EDEM2
-
Hintergrund
-
Synonyms: ER degradation-enhancing alpha-mannosidase-like protein 2|EDEM2|C20orf31|C20orf49
Background: Initiates the endoplasmic reticulum-associated degradation(ERAD) that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner. Catalyzes the first mannose trimming step, from Man9GlcNAc2 to Man8GlcNAc2(PubMed:25092655). Extracts misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle.
-
Molekulargewicht
- 60-65 kDa
-
Gen-ID
- 55741
-
UniProt
- Q9BV94
Target
-